Results 261 to 270 of about 210,707 (288)

Aflibercept in real-life for the treatment of age-related macular degeneration using a treat and extend protocol: The Armada study

European Journal of Ophthalmology, 2022
Pierre Gascón, Alban Comet, Sébastien Kerever   +2 more
exaly  

Extending expertise in treating extravasation

Cancer Nursing Practice, 2011
openaire   +1 more source

Treating Patients, Treating Our Planet: Extending the Moral Imperative Beyond Desflurane

Anesthesia & Analgesia
Ying-Yu, Wang, Yi-Han, Peng, Ming-Hui, Hung   +2 more
openaire   +2 more sources

Results of Switching from Pro Re Nata to Treat-and-Extend Regimen in Treatment of Patients with Type 3 Neovascularization

Seminars in Ophthalmology, 2020
Jae Hui Kim
exaly  

Results of patients with neovascular age-related macular degeneration managed by a treat-extend-stop protocol without recurrence

Graefe's Archive for Clinical and Experimental Ophthalmology, 2021
Sean Adrean, Siyang Chaïli
exaly  

Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration

Ophthalmology, 2018
Silva R, Michael Larsen, András Berta   +2 more
exaly  

Two-Year Outcomes of “Treat and Extend” Intravitreal Therapy for Neovascular Age-Related Macular Degeneration

Ophthalmology, 2015
Judy M Simpson, Rohan Essex, Gayatri Banerjee   +2 more
exaly  

Comparison of two different treat‐and‐extend protocols with aflibercept in wet age‐related macular degeneration

Acta Ophthalmologica, 2020
Claudia Taipale, Raimo Tuuminen, Juha-Matti Lindholm   +2 more
exaly  

Canadian Treat-and-Extend Analysis Trial with Ranibizumab in Patients with Neovascular Age-Related Macular Disease

Ophthalmology, 2019
Tom Sheidow, Peter Kertes, Geoff Williams   +2 more
exaly  

Comparison of 2-Year Outcomes between Intravitreal Ranibizumab and Intravitreal Aflibercept for Diabetic Macular Edema with “Treat-and-Extend” Regimen—Its Usefulness and Problems

Journal of Clinical Medicine, 2020
Masahiko Sugimoto, Yoshitsugu Matsui, Hisashi Matsubara   +2 more
exaly